Journal of Otolaryngology and Reconstructive Surgery

Editor in Chief

Dr. Afshin Teymoortash received his doctorate in the Department of Medicine at University of Kiel. He is Specialist in ear, nose &throat medicine and facial plastic surgery. His research areas include Head and neck oncology, plastic reconstructive surgery of the head and neck, salivary gland diseases. He is Co-Chairman of the Department of Otorhinolaryngology, Head and Neck Surgery at the Philipp…

Name : Afshin Teymoortash
University : Philipp University

Indexing and Listing

          

Recent Articles

  • article image

    Surgical and Medical Management of Sinus Mucosal and Systemic Mycotoxicosis

    Two women, ages 53 and 26, exposed to fungi in their water-damaged homes, presented with sinus and neurological symptoms. Sinus CT scans revealed bilateral fungal ethmoid sinusitis in both patients. The older patient also had a brain MRI that indicated probable microvascular inflammation in the grey and white matter junction. After maximal medical…

    View more
  • article image

    The Nijmegen Auricle Consultation: How We Do It?

    The quality of healthcare optimization for patients with an absent or a deformed auricle is of great importance. The absence of the auricle has various causes, and the management differs between patients with congenital microtia and patients with amputated ears due to a malignant tumor or trauma. Auricular reconstruction using autogenous rib cartilage…

    View more
  • article image

    Ceruminous Gland Adenoma of External Auditory Canal- A Case Report

    Ceruminous Adenoma (CA) is a benign neoplasm of ceruminous glands. Developing exclusively in the external auditory canal (EAC) with benign clinical behavior and was first reported by Hang in 1894. It is rare in humans and poses a diagnostic problem for the clinician, due to the variety of clinical presentations. This tumor is mainly composed of the…

    View more

PubMed Indexed Articles

  • article image

    Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • article image

    Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • article image

    Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Testimonial